Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Dividends-Paid" stands at 12.23 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Johnson & Johnson's third quarter result of 3.13 Billion USD for the item "Dividends Paid" represents an increase of 0.1 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 3.13 Billion USD for the item "Dividends Paid" represents an increase of 4.92 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 12.23 Billion USD for the item "Dividends Paid" represents an increase of 1.22 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.53 percent compared to the value the year prior.
The 1 year change in percent is 4.53.
The 3 year change in percent is 6.21.
The 5 year change in percent is 18.51.
The 10 year change in percent is 51.84.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Dividends Paid | 905,699,262,464.00 |
![]() | AbbVie Inc - Dividends Paid | 399,570,305,024.00 |
![]() | Roche Holding AG - Dividends Paid | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Dividends Paid | 280,205,508,085.11 |
![]() | Novartis AG - Dividends Paid | 255,096,620,580.91 |